BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

CAXTON ASSOCIATES LLP's Holding History (CIK: 0002051323)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 38,144 Value ($000) $298 Avg Close $7.23 Range $6.00 - $8.17

Q3 2025

Shares 15,712 Value ($000) $119 Avg Close $8.33 Range $7.42 - $9.23

Q2 2025

Shares 28,379 Value ($000) $254 Avg Close $9.31 Range $6.02 - $11.31

Q1 2025

Shares 41,929 Value ($000) $314 Avg Close $8.07 Range $6.96 - $9.50

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	38,144	$298	$7.23	$6.00 - $8.17
Q3 2025	15,712	$119	$8.33	$7.42 - $9.23
Q2 2025	28,379	$254	$9.31	$6.02 - $11.31
Q1 2025	41,929	$314	$8.07	$6.96 - $9.50